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This ‘Cochrane Corner’ offers evidence relating to 
articles published in the August issue of SAMJ, namely 
‘Improving access to antiretrovirals in rural South 
Africa – a call to action’,[1] ‘Multimorbidity, control 
and treatment of non-communicable diseases among 
primary healthcare attenders in the Western Cape, South Africa’[2] and 
‘Prevalence of tobacco use among adults in South Africa: Results from 
the first South African National Health and Nutrition Examination 
Survey,’[3] and the editorial by Yach and Alexander, ‘Turbo-charging 
tobacco control in South Africa’.[4]
Task-shifting from doctors to non-
doctors for initiation and maintenance 
of antiretroviral therapy
(Summary prepared by T Kredo, with M McCaul and J Volmink.)
About 30 million people living with HIV worldwide are eligible for 
antiretroviral therapy (ART), but less than half access treatment. [5] 
Healthcare worker shortages are an impediment to increasing patients’ 
access to ART. This is of particular concern where the burden of disease 
is greatest and the number of doctors is limited. To improve access, 
some low- and middle-income countries have initiated programmes 
that support the delivery of ART by non-specialist healthcare providers. 
However, some have raised concerns that this may cause more harm 
than good. In this Cochrane column, we highlight a Cochrane review[6] 
that evaluated the quality of initiation and maintenance of HIV/AIDS 
treatment in models that shift care from doctors to non-doctors. The 
results of this review informed the recommendations of the WHO 
consolidated guidelines for ART in 2013.[7]
A comprehensive search conducted up to March 2014 identified all 
relevant controlled trials and cohort studies comparing doctor-led to 
other health worker-led delivery of ART. 
Four randomised controlled trials and six cohort studies are 
included, all conducted in Africa.
When nurses initiate and provide maintenance ART, there is no 
difference in death at 1 year (risk ratio (RR) 0.96, 95% confidence 
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Table 1. Summary of findings: task shifting of HIV care for maintenance only – 12 months’ follow-up
Population: HIV-infected patients on antiretroviral therapy 
Settings: Low- and middle-income countries 
Intervention: Doctor v. nurse or clinical officer for maintenance of antiretroviral therapy
Outcomes
Illustrative comparative risks* (95% CI) Relative effect 
(95% CI)
Number of participants 
(studies)
Quality of the evidence 
(GRADE†)Doctors Non-doctors 
Death (RCTs) 23 per 1 000 20 per 1 000 
(14 - 30)
RR 0.89  
(0.59 - 1.32)
4 332 
(2 studies)
+++– 
Moderate‡1
Death (cohorts) 15 per 1 000 3 per 1 000 
(1 - 12)
RR 0.19  
(0.05 - 0.78)
2 772 
(1 study)
+––– 
Very low‡2
Loss to follow-up (RCTs) 28 per 1 000 36 per 1 000 
(26 - 49)
RR 1.27  
(0.92 - 1.77)
4 332 
(2 studies)
+++– 
Moderate‡3
Loss to follow-up (cohorts) 42 per 1 000 14 per 1 000 
(8 - 28)
RR 0.34  
(0.18 - 0.66)
2 772 
(1 study)
+––– 
Very low‡2
CI = confidence interval; RCTs = randomised control trials; RR = risk ratio.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison 
group and the relative effect of the intervention (and its 95% CI). 
†GRADE: Working group grades of evidence: 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important effect on our confidence in the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important effect on our confidence in the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate.
‡1 Downgraded by 1 for imprecision. There was a low number of events (<300) and the 95% CI includes appreciable harm and benefit.
 2 Downgraded by 1 for imprecision owing to low event numbers (<300).
 3 Downgraded by 1 for imprecision. There was a low number of events (<300) after adjusting for clustering in the Fairall et al.[8] 2012 study. 
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interval (CI) 0.82 - 1.12, one trial, cluster 
adjusted n=2  770; high-quality evidence), 
with probably lower rates of loss to follow-
up (RR 0.73, 95% CI 0.55 - 0.97, moderate-
quality evidence). 
When doctors initiate ART and nurses 
provide maintenance, there is probably no 
difference in death compared with doctor-
led care at 1 year (RR 0.89, 95% CI 0.59  - 
1.32, two trials, cluster adjusted n=4 332, 
moderate-quality evidence), with probably 
no difference in the rate of loss to follow-up 
(RR 1.27, 95% CI 0.92 - 1.77, moderate-
quality evidence).
When maintenance therapy is provided 
in the community, there is probably no 
difference in mortality at 1 year when 
doctors deliver care in the hospital or 
specially trained field workers provide 
home-based maintenance of ART (RR 1.0, 
95% CI 0.62 - 1.62, one trial, cluster adjusted 
n=559, moderate-quality evidence), and 
probably no difference in loss to follow-up 
(RR 0.52, 95% CI 0.12 - 2.3, moderate-
quality evidence).
Travel costs for patients are lower 
where task-shifting occurs closer to 
patients’ homes. Evidence suggests that 
the implementation of the strategy may 
increase health system costs, in particular 
related to training and supervision.
Conclusion 
Shifting responsibility for providing ART 
from doctors to adequately trained and 
supported nurses or community health 
workers probably does not decrease the 
quality of care and may decrease the number 
of patients lost to follow-up. 
Motivational interviewing 
for smoking cessation
(Summary prepared by M McCaul, with 
T Kredo and J Volmink.)
Smoking kills.[9] Fortunately, several pharma-
cological and non-pharmacological inter-
ven tions are available to help smokers quit. [10] 
Motivational interviewing is a psycho-
therapeutic approach for effecting behaviour 
change. It originated in the treatment of 
alcohol abuse as ‘a directive, client-centred 
counselling [approach] for eliciting 
behaviour change by helping clients to 
explore and resolve ambivalence’.[11] Here we 
highlight a Cochrane review[12] that updates 
the original 2007 review investigating 
whether motivational interviewing promotes 
smoking cessation compared with simple 
advice or usual care. 
A comprehensive search conducted 
in August 2014 identified all relevant 
randomised controlled trials evaluating 
the effects of motivational interviewing for 
smoking cessation.
Twenty-nine trials are included (14 added 
since 2007), all of which provided data for 
meta-analysis.
Motivational interviewing for smoking 
cessation is moderately effective compared 
with brief advice or usual care, using 
the strictest definition of abstinence and 
longest follow-up period (at least 6 months) 
(RR  1.26, 95% CI 1.16 - 1.36, 28 trials, 
n=16 803, moderate-quality evidence). 
Subgroup analysis by type of therapist 
indicated that interventions delivered 
by gene ral practitioners (RR 3.49, 95% 
CI  1.53 - 7.94, two trials, n=736) may 
have larger effects than those delivered by 
nurses (RR=1.24, 95% CI 0.91 - 1.68, five 
trials, n=2  256) or counsellors (RR 1.25; 
95% CI 1.15 - 1.36, 22 trials, n=13 593). 
Larger effects were found with sessions 
lasting <20 minutes (RR 1.69, 95% 
CI 1.34  - 2.12, nine trials, n=3 651) than 
with sessions >20 minutes (RR 1.20, 95% 
CI 1.08 - 1.32, 16 trials, n=10 306). 
The authors noted variations in study 
quality and treatment fidelity, as well 
as between study heterogeneity and the 
possibility of publication or selective 
reporting bias (Fig. 1).
Conclusion 
Motivational interviewing appears to be 
modestly successful in promoting smoking 
cessation, compared with usual care or brief 
advice. 
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Fig. 1. Funnel plot of motivational interviewing v. brief advice/usual care: All trials, outcome: smoking 
cessation: longest duration and strictest definition of abstinence.
